Tandem Diabetes Care Inc (NASDAQ: TNDM) open the trading on Wednesday, with great promise as it jumped 2.57% to $14.75, before settling in for the price of $14.38 at the close. Taking a more long-term approach, TNDM posted a 52-week range of $9.98-$38.28.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -28.23%. Meanwhile, its Annual Earning per share during the time was -28.23%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -41.93%. This publicly-traded company’s shares outstanding now amounts to $67.53 million, simultaneously with a float of $66.88 million. The organization now has a market capitalization sitting at $996.65 million.
Tandem Diabetes Care Inc (TNDM) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Devices industry. Tandem Diabetes Care Inc’s current insider ownership accounts for 1.02%, in contrast to 120.97% institutional ownership. According to the most recent insider trade that took place on Aug 11 ’25, this organization’s PRESIDENT & CEO bought 10,000 shares at the rate of 10.23, making the entire transaction reach 102,318 in total value, affecting insider ownership by 106,327. Preceding that transaction, on Aug 08 ’25, Company’s EVP & CHIEF FINANCIAL OFFICER bought 13,720 for 10.89, making the whole transaction’s value amount to 149,404. This particular insider is now the holder of 25,580 in total.
Tandem Diabetes Care Inc (TNDM) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
Tandem Diabetes Care Inc’s EPS decrease for this current 12-month fiscal period is -41.93% and is forecasted to reach -0.92 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 46.37% through the next 5 years, which can be compared against the -28.23% growth it accomplished over the previous five years trading on the market.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Let’s observe the current performance indicators for Tandem Diabetes Care Inc (TNDM). It’s Quick Ratio in the last reported quarter now stands at 1.88. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.99.
In the same vein, TNDM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.09, a figure that is expected to reach -0.33 in the next quarter, and analysts are predicting that it will be -0.92 at the market close of one year from today.
